Neurally Adjusted Ventilatory Assist for Non Invasive Ventilation and Patient-ventilator Interaction
NCT ID: NCT01074866
Last Updated: 2012-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2010-07-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pressure support
Non invasive ventilation under pressure support (PS)
No interventions assigned to this group
Neurally Adjusted Ventilatory Assist
Non invasive ventilation under Neurally Adjusted ventilatory Assist
Neurally Adjusted Ventilatory Assist
Non invasive ventilation under Neurally adjusted Ventilatory Assist
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neurally Adjusted Ventilatory Assist
Non invasive ventilation under Neurally adjusted Ventilatory Assist
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* hemodynamic instability
* known oesophageal problem
* active upper gastro-intestinal bleeding
* any other contraindication to the insertion of a naso-gastric tube
* impaired consciousness or absence of patient cooperation
* facial or laryngeal lesions contraindicating the use of NIV
* poor short term prognosis
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital St Luc, Brussels
OTHER
University Hospital Sart Tilman, Liege
UNKNOWN
University of Lausanne Hospitals
OTHER
Notre Dame de Grace Hospital, Gosselies
UNKNOWN
University Hospital, Geneva
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
HUG, University hospital of Geneva
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Didier Tassaux, MD
Role: STUDY_DIRECTOR
HUG, University hospital Geneva
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St Luc University hospital
Brussels, , Belgium
Bernard Lambermont
Liège, , Belgium
HUG, University Hospital
Geneva, , Switzerland
CHUV University hospital of Lausanne
Lausanne, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NAVA_NIV
Identifier Type: -
Identifier Source: org_study_id